Ad
related to: pfizer wikipedia videos
Search results
Results From The WOW.Com Content Network
Pfizer Inc. (/ ˈ f aɪ z ər / FY-zər) [3] is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849, in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing.
Pages in category "Drugs developed by Pfizer" The following 200 pages are in this category, out of approximately 240 total. This list may not reflect recent changes .
Pfizer–BioNTech's BNT162b2 mRNA vaccine has to be kept between −80 and −60 °C (−112 and −76 °F). [ 86 ] [ 87 ] Moderna says their mRNA-1273 vaccine can be stored between −25 and −15 °C (−13 and 5 °F), [ 88 ] which is comparable to a home freezer, [ 87 ] and that it remains stable between 2 and 8 °C (36 and 46 °F) for up to ...
In 1849, he borrowed US$2,500 from his father to buy a commercial building in Williamsburg, Brooklyn.He then co-founded Chas. Pfizer & Co. Inc. [11] Due to Pfizer's experience in chemistry and his partner's background as a confectioner, the company was initially engaged in the manufacture of food flavorings, iodine preparations, and citric acid for softdrink production. [5]
In November 2021, Pfizer signed a license agreement with the United Nations–backed Medicines Patent Pool to allow nirmatrelvir to be manufactured and sold in 95 countries. [25] Pfizer stated that the agreement will allow local medicine manufacturers to produce the pill "with the goal of facilitating greater access to the global population".
From Wikipedia, the free encyclopedia. Redirect page. Redirect to: Pfizer–BioNTech COVID-19 vaccine; Retrieved from " ...
He was appointed President of R&D at the American Pharma Wyeth 2008. Dolsten joined Pfizer in 2009 during the acquisition of Wyeth as Head of BioTherapeutics. He became Pfizer's Chief Scientific Officer and President of R&D on 26 May 2010, replacing Martin Mackay, who moved to the UK as head of research for AstraZeneca.